WRAP53 and non-small cell lung carcinoma: Abnormal TCAB1 expression has been observed in nasopharyngeal [15], esophageal[16], rectal [17], breast [18], ovarian cancers [19], and recently in non-small cell lung cancer (NSCLC) as well[20].